I agree that this site is using cookies. You can find further informations here.
X
Krippendorff, Ben-Fillippo
25  results:
Search for persons X
?
1

Diligent Design Enables Antibody-ASO Conjugates with Optima..:

Sela, Tatjana ; Mansø, Mads ; Siegel, Michel...
Bioconjugate Chemistry.  34 (2023)  11 - p. 2096-2111 , 2023
Link: https://doi.org/10.1021/..
 
?
2

Translating pharmacology models effectively to predict ther..:

Dudal, Sherri ; Bissantz, Caterina ; Caruso, Antonello...
Drug Discovery Today.  27 (2022)  6 - p. 1604-1621 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Influence of Molecular size on the clearance of antibody fr..:

Li, Zhe ; Krippendorff, Ben-Fillippo ; Shah, Dhaval K.
Pharmaceutical Research.  34 (2017)  10 - p. 2131-2141 , 2017
Link: https://doi.org/10.1007/..
 
?
4

A re-engineered immunotoxin shows promising preclinical act..:

Kollmorgen, Gwendlyn ; Palme, Klara ; Seidl, Annette...
Scientific Reports.  7 (2017)  1 - p. , 2017
Link: https://doi.org/10.1038/..
 
?
5

Characterization of a re‐engineered, mesothelin‐targetedPse..:

Bauss, Frieder ; Lechmann, Martin ; Krippendorff, Ben-Fillippo...
Molecular Oncology.  10 (2016)  8 - p. 1317-1329 , 2016
Link: https://doi.org/10.1016/..
 
?
6

The EGFR demonstrates linear signal transmission:

Oyarzún, Diego A. ; Bramhall, Jo L. ; López-Caamal, Fernando...
Integr. Biol..  6 (2014)  8 - p. 736-742 , 2014
Link: https://doi.org/10.1039/..
 
?
7

Anti-Tumour Efficacy of Capecitabine in a Genetically Engin..:

Courtin, Aurélie ; Richards, Frances M. ; Bapiro, Tashinga E....
PLoS ONE.  8 (2013)  6 - p. e67330 , 2013
Link: https://doi.org/10.1371/..
 
?
8

G-Quadruplex DNA as a Molecular Target for Induced Syntheti..:

McLuckie, Keith I. E. ; Di Antonio, Marco ; Zecchini, Heather...
Journal of the American Chemical Society.  135 (2013)  26 - p. 9640-9643 , 2013
Link: https://doi.org/10.1021/..
 
?
9

Predicting the F(ab)-mediated effect of monoclonal antibodi..:

Krippendorff, Ben-Fillippo ; Oyarzún, Diego A. ; Huisinga, Wilhelm
Journal of Pharmacokinetics and Pharmacodynamics.  39 (2012)  2 - p. 125-139 , 2012
Link: https://doi.org/10.1007/..
 
?
10

Mechanism-Based Inhibition: Deriving KI and kinact Directly..:

Krippendorff, Ben-Fillippo ; Neuhaus, Roland ; Lienau, Philip..
SLAS Discovery.  14 (2009)  8 - p. 913-923 , 2009
Link: https://doi.org/10.1177/..
 
?
11

Nonlinear pharmacokinetics of therapeutic proteins resultin..:

Krippendorff, Ben-Fillippo ; Kuester, Katharina ; Kloft, Charlotte.
Journal of Pharmacokinetics and Pharmacodynamics.  36 (2009)  3 - p. 239-260 , 2009
Link: https://doi.org/10.1007/..
 
?
12

Optimizing Classification of Drug-Drug Interaction Potentia..:

Krippendorff, Ben-Fillippo ; Lienau, Philip ; Reichel, Andreas.
SLAS Discovery.  12 (2007)  1 - p. 92-99 , 2007
Link: https://doi.org/10.1177/..
 
?
13

Predicting the F(ab)-mediated effect of monoclonal antibodi..:

Krippendorff, Ben-Fillippo ; Oyarzún, Diego A ; Huisinga, Wilhelm (Prof. Dr.)
https://publishup.uni-potsdam.de/frontdoor/index/index/docId/43105.  , 2020
Link: https://publishup.uni-po..
 
?
14

Capacity limits of asialoglycoprotein receptor-mediated liv..:

Bon, Charlotte ; Hofer, Thomas ; Bousquet-Mélou, Alain..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680813/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
15

Influence of molecular size on the clearance of antibody fr..:

Li, Zhe ; Krippendorff, Ben-Fillippo ; Shah, Dhaval K
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693627/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
1-15